Printer Friendly

GRANT JOINS CORTEX BOARD

 GRANT JOINS CORTEX BOARD
 IRVINE, Calif., July 1 /PRNewswire/ -- Cortex Pharmaceuticals, Inc.


(NASDAQ: CORX) today announced the appointment of James D. Grant to the company's board of directors. Grant, 59, is chairman, and from 1986 to 1992 was chief executive officer, of T Cell Sciences, Inc., a Cambridge, Mass.-based biotechnology pharmaceutical company. From 1972 to 1986 he was a vice president and corporate officer of CPC International Inc., a Fortune 100 multinational food industrial products company. From 1969 to 1972, Grant served as deputy commissioner of the U.S. Food and Drug Administration, and was vice chairman of the advisory committee on the FDA (the "Edwards Committee") in 1990 and 1991.
 "Jim's experience, both with the FDA and in the biopharmaceutical industry, will be of great benefit to Cortex as it continues to build on its technological foundation and begins to make the transition to a product-oriented company with internal clinical, regulatory and marketing functions," said Dr. Harvey Sadow, chairman of Cortex.
 Grant said, "I am impressed with the breadth and depth of technology at Cortex. The company is targeting major medical problems for which there are no currently available treatments, and has demonstrated, with its calpain inhibitors for stroke, that it has the ability to advance rapidly from concept to drug candidate. I am looking forward to working with the Cortex team."
 Grant holds an MBA from the Wharton School of the University of Pennsylvania and a bachelor's degree in chemistry from the College of William and Mary, and he did postgraduate study at Stanford University on a Ford Foundation fellowship. He fills an existing vacancy on the board of directors.
 Cortex is a neurological drug discovery company that is developing products for the treatment and diagnosis of age-related diseases and disorders of the brain.
 -0- 7/1/92
 /CONTACT: Scott Hagen of Cortex, 714-727-3157, or Fred Spar of Kekst & Co., 212-593-2655, for Cortex/
 (CORX) CO: Cortex Pharmaceuticals, Inc. ST: California IN: MTC SU: PER


AL -- LA018 -- 5719 07/01/92 12:48 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 1, 1992
Words:336
Previous Article:BASF COMPLETES RESTRUCTURING OF MAGNETIC MEDIA BUSINESS
Next Article:BTi AND UNIVERSITY OF RENNES ESTABLISH DEVELOPMENT PROJECT
Topics:


Related Articles
SHALSON RESIGNS AS PRESIDENT & CEO OF CORTEX
CORTEX ANNOUNCES APPOINTMENT OF INTERIM PRESIDENT & CEO
SCOTT HAGEN NAMED CORTEX CFO
ALAN STEIGROD NAMED CORTEX PRESIDENT & CHIEF EXECUTIVE OFFICER
JEROME M. ARNOLD JOINS CORTEX BOARD OF DIRECTORS
CORTEX APPOINTS DAVIS TEMPLE, Ph.D., TO BOARD OF DIRECTORS
CORTEX ANNOUNCES MANAGEMENT CHANGES
VINCENT SIMMON NAMED CORTEX PRESIDENT AND CEO
Charles J. Casamento Joins Cortex Board of Directors
Cortex Names Dr. Ursula Staubli as Vice President of Biological Research.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters